
The Federal Office for Competition Regulation (Bkarta) is intensifying its focus on Germany’s electricity market, aiming to address the persistently high prices faced by consumers. This initiative was confirmed by Andreas Mundt, president of the Bkarta, in a recent announcement.
According to Mundt, the agency has been “continuously and closely monitoring price formation on the electricity market.” He noted that recent challenges, such as operating with a reduced fleet of power plants for the first time this winter, have led to significant fluctuations in electricity prices. While these variations could reflect a natural market outcome, the agency plans to keep a vigilant eye on price trends in the coming months and intervene if necessary.
Periods of “dark pauses,” where renewable energy sources like solar and wind are unavailable due to conditions such as nighttime or a lack of wind, are a particular area of concern. Per the statement from Mundt, these dark pauses can create gaps in energy production, potentially leading to spikes in electricity prices.
The Federal Network Agency, Germany’s energy regulator, is also stepping up its oversight. It recently announced plans to examine any “evidence of abusive behavior on electricity prices during dark pauses.” This additional scrutiny complements the work of the Bkarta and highlights the government’s commitment to ensuring fair market practices in the energy sector.
Source: Agenzia Nova
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas